Skip to Content

Apellis Pharmaceuticals

APLS

Buy $APLS at eToro
Rank 3045
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 6400 WESTWIND WAY, SUITE A, CRESTWOOD, KY, US

Apellis Pharmaceuticals - Key figures

Market cap 4.81 Billion
Revenue 80.94 Million
Profit -253,920,000
P/E Ratio No information
P/s Ratio 59.47
Buy $APLS at eToro

Apellis Pharmaceuticals - Description

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through inhibition of the complement system for autoimmune and inflammatory diseases.

The company is headquartered in Waltham, Massachusetts.